1 |
Turk, B., D. Turk, and V. Turk. 2000. Lysosomes cysteine proteases; more that scavengers. Biochim. Biophys. Acta. 1477, 98-111
DOI
ScienceOn
|
2 |
van der Stappen, J. W., A. C. Williams, R. A. Maciewicz, and C. Paraskeva. 1996. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int. J. Cancer 67, 547-554
DOI
ScienceOn
|
3 |
Warwas, M., H. Haczynska, J. Gerber, and M. Nowak. 1997. Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 35, 301-304
|
4 |
Puente, X. S., L. M. Sanchez, C. M. Overall, and C. Lopez-Otin. 2003. A genomic analysis of rat proteases and protease inhibitors. Nat. Rev. Genet. 4, 544-558
DOI
ScienceOn
|
5 |
Rochefort, H., M. Garcia, M. Glondu, V. Laurent, E. Liaudet, J. M. Rey, and P. Roger. 2000. Cathepsin D in breast cancer: Mechanisms and clinical applications, a 1999 overview. Clin. Chim. Acta. 291, 157-170
DOI
ScienceOn
|
6 |
Schmitt, M., F. Janicke, N. Moniwa, L. Chucholowski, H. Pache, and H Graeff. 1992. Tumor-associated urokinase-type plasminogen activator: Biological and clinical significance. BioI. Chem. Hoppe. Seyler 373, 611-622
DOI
ScienceOn
|
7 |
Shuja, S., J. Cai, C. Iacobuzio-Donahue, J. Zacks, R. M. Beazley, J. M. Kasznica, C. J. O'Hara, R. Heimann, and M. J. Murnane. 1999. Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters. Thyroid 9, 569-577
DOI
ScienceOn
|
8 |
Shuja, S., and M. J. Murnane. 1996. Marked increases in cathepsin Band L activities distinguish papillary carcinomaof the thyroid from normal thyroid or thyroid with non-neoplastic disease. Int. J. Cancer 66, 420-426
DOI
ScienceOn
|
9 |
Skrzydlewska, E., M. Sulkowska, M. Koda, and S. Sulkowski. 2005. Proteolytic-anti proteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 11, 1251-1266
DOI
|
10 |
Skrzydlewska, E., M. Sulkowska, A. Wincewicz, M. Koda, and S. Sulkowski. 2005. Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J. Gas troen terol. 11, 4225-4229
|
11 |
Sloane, B. F. 1990. Cathepsin Band cystatins: Evidence for a role in cancer progression. Semin. Cancer BioI. 1, 137-152
|
12 |
Towbin, H., and J. Gordon. 1984. Immunoblotting and dot immunoblotting; current status and outlook. J. Immunol. Methods 72, 313-318
DOI
ScienceOn
|
13 |
Kos, J., B. Stabuc, A. Schweiger, M. Krasovec, N. Cimerman, N. Kopitar-Jeralla, and I. Vrhovec. 1997. Cathepsin B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3, 1815-1822
|
14 |
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
DOI
ScienceOn
|
15 |
Lah, T. T., M. Cercek, A. Blejec, J. Kos, E. Gorodetsky, R. Somers, and I. Daskal. 2000. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin. Cancer Res. 6, 578-584
|
16 |
Leto, G., F. M. Tumminello, G. Pizzolanti, G. Montalto, M. Soresi, and N. Gebbia. 1997. Lysosomal cathepsins Band L blood level in patients with hepatocellular carcinoma and/ or liver cirrhosis: Potential clinical implications. Oncology 54, 79-83
DOI
ScienceOn
|
17 |
Ljusberg, J., Y. Wang, P. Lang, M. Norgard, R. Dodds, K. Hultenby, B. Ek-Rylander, and G. Andersson. 2005. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J. BioI. Chem. 280, 28370-28381
DOI
ScienceOn
|
18 |
Oh-e, H., S. Tanaka, Y. Kitadai, F. Shimamoto, M. Yoshihara, and K. Haruma. 2001. Cathepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer. Eur. J. Cancer 37, 180-188
DOI
ScienceOn
|
19 |
Miyake, H., I. Hara, and H. Eto. 2004. Serum level of cathe psin B and its density in men with prostate cancer as novel markers of disease progression. Anticancer Res. 24, 2573-2577
|
20 |
Nishikawa, H., Y. Ozaki, T. Nakanishi, K. Blomgren, T. Tada, A. Arakawa, and K. Suzumori. 2004. The role of cathepsin Band cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol. Oncol. 92, 881-886
DOI
ScienceOn
|
21 |
Curran, S. and G. I. Murray. 1999. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 189, 300-308
DOI
ScienceOn
|
22 |
Foekens, J. A., M. P. Look, Bolt-de, J. Vries, Meijer-van, M. E. Gelder, van, W. L. Putten, and J. G. Klijn. 1999. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br. J. Cancer 79, 300-307
DOI
|
23 |
Gocheva, V., W. Zeng, D. Ke, D. Klimstra, T. Reinheckel, C. Peters, D. Hanahan, J. A. Joyce. 2006. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556
DOI
ScienceOn
|
24 |
Hazen, L. G., F. E. Bleeker, B. Lauritzen, S. Bahns, J. Song, A. Jonker, Van B. E. Driel, H. Lyon, U. Hansen, A. Kohler, and Van C. J Noorden. 2000. Comparative localization of cathepsin B protein and activity in colorectal cancer. J. Histochem. Cytochem. 48, 1421-1430
DOI
ScienceOn
|
25 |
Joyce, J. A., A. Baruch, K. Chehade, N. Meyer-Morse, E. Giraudo, F. Y. Tsai, D. C. Greenbaum, J. H. Hager, M. Bogyo, and D. Hanahan. 2004. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443-453
DOI
ScienceOn
|
26 |
Chabowski, A., M. Sulkowska, S. Sulkowski, W. Famulski, E. Skrzydlewska, and W. Kisielewski. 2001. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer. Histochem. Cytobiol. 39, 153-154
|
27 |
Keene, E. W., G. M. Petit, S. Allen, and H. J. McKerrow. 1986. The major neutral proteinase of Entamoeba histolytica. J. Exp. Med. 163, 536-549
DOI
ScienceOn
|
28 |
Kirchke, H., R. Eerola, V. K. Hopsu-Havu, D. Bromme, and E. Vuorio. 2000. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur. J. Cancer. 36, 787-795
DOI
ScienceOn
|
29 |
Koblinski, J. E., M. Ahram, and B. F. Sloane. 2000. Unraveling the role of proteases in cancer. Clin. Chim. Acta. 291, 113-135
DOI
ScienceOn
|
30 |
Aznavoorian, S. and A. N. Wurphy.1993. Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368-1383
DOI
ScienceOn
|
31 |
Coussens, L. M., B. Fingleton, and L. M. Matrisian. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392
DOI
ScienceOn
|